ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
205.50
-0.65
(-0.32%)
At close: April 25 4:00PM
205.50
-0.65
( -0.32% )
After Hours: 6:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
205.50
Bid
-
Ask
-
Volume
261,670
201.01 Day's Range 206.66
180.93 52 Week Range 348.67
Market Cap
Previous Close
206.15
Open
204.22
Last Trade
35724
@
205.5
Last Trade Time
16:10:00
Financial Volume
$ 53,463,697
VWAP
204.3173
Average Volume (3m)
352,538
Shares Outstanding
38,703,659
Dividend Yield
-
PE Ratio
87.40
Earnings Per Share (EPS)
2.35
Revenue
1.06B
Net Profit
90.95M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Dover, Delaware, USA
Founded
1970
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $206.15. Over the last year, Penumbra shares have traded in a share price range of $ 180.93 to $ 348.67.

Penumbra currently has 38,703,659 shares outstanding. The market capitalization of Penumbra is $7.95 billion. Penumbra has a price to earnings ratio (PE ratio) of 87.40.

Penumbra (PEN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-9M

Calls / Puts

25.00%

Buys / Sells

400.00%

OTM / ITM

25.00%

Sweeps Ratio

0.00%

PEN Latest News

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots PR Newswire ALAMEDA, Calif., April 23, 2024 Lightning Flash™ 2.0 features advanced computer...

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 PR Newswire ALAMEDA, Calif., April 9, 2024 ALAMEDA, Calif., April 9, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.65-1.2731203459208.15209.005199.38349158203.93921116CS
4-20.57-9.09895165214226.07228.43199.38300752213.30146578CS
12-47.5-18.7747035573253277.34199.38352538233.69622478CS
260.360.17548990933205.14277.34180.93369423229.14140986CS
52-81.29-28.3447818962286.79348.67180.93376975255.88664718CS
156-94.18-31.4268553123299.68348.67114.865309694230.57500987CS
26071.4953.3467651668134.01348.67107.5360911210.13879077CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.24
(45.88%)
242.28k
PEGYPineapple Energy Inc
$ 0.0702
(35.26%)
45.04M
ELWSEarlyworks Co Ltd
$ 0.965
(31.23%)
2.15M
GGLLDirexion Daily GOOGL Bull 2X ETF
$ 44.69
(24.07%)
189.04k
GNPXGenprex Inc
$ 2.52
(18.87%)
228
VINCVincerx Inc
$ 0.74
(-17.48%)
359.18k
ACONAclarion Inc
$ 0.33
(-15.97%)
1.5M
ISUNiSun Inc
$ 0.1476
(-14.29%)
4.82M
WORXSCWorx Corporation
$ 2.3694
(-14.15%)
349.96k
ATXIAvenue Therapeutics Inc
$ 0.1014
(-13.33%)
468.38k
PEGYPineapple Energy Inc
$ 0.0702
(35.26%)
45.04M
GOOGLAlphabet Inc
$ 174.90
(12.12%)
11.03M
SQQQProShares UltraPro Short QQQ
$ 11.59
(-3.42%)
8.72M
INTCIntel Corporation
$ 32.44
(-7.60%)
7.57M
GOOGAlphabet Inc
$ 176.909
(12.00%)
5.7M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 3 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 3 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 9 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 9 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 9 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

Delayed Upgrade Clock